Dr. Nicola Mason
Veterinary immunologist and cancer researcher
Comparative oncology • cancer immunotherapy • CAR T-cell + mRNA cancer therapies
About the expert
Focus: Cutting-edge cancer immunotherapy research bridging veterinary and human medicine through the One Health framework
Professor at the University of Pennsylvania School of Veterinary Medicine. Leads the Cancer Moonshot Canine Immunotherapy Network, the NIH/NCI initiative using spontaneously occurring canine cancers as a translational model for human cancer immunotherapy. Her lab works on CAR T-cell therapies derived from healthy donors (off-the-shelf approaches) and mRNA technology that prompts the patient's own body to produce cancer-fighting antibodies. Mainstream-anchored research credentials at the highest tier of academic veterinary oncology.
Why this matters
Helps explain why pet cancer research benefits both species (spontaneous canine tumors are a more realistic model than lab mice for human cancer), and what immunotherapy approaches (CAR T-cell, mRNA antibodies) may become available for both pets and humans in coming years. Strongest on translational research and immunotherapy pipeline. Mainstream-anchored, mainly published at the academic research frontier. Commercial layer: episode produced by ImpriMed (precision diagnostics sponsor); her own research funding is academic + NIH.
Topics covered
None of Dr. Nicola Mason's linked topics match the Human lens. Switch the species filter above to see this expert's other work.
Episodes with Dr. Nicola Mason
Dr. Nicola Mason has 1 episode in the catalog, but none match the Human lens. Switch the species filter above to see this expert's work.